PHARMING GRP SP. ADRS Capital Reinvestment Ratio
PHARMING GRP SP. ADRS capital reinvestment ratio. PHARMING GRP SP. ADRS (PHG) has a Capital Reinvestment Ratio of 0.03x as of December 2025, meaning it reinvests 0% of its operating cash flow (€10.71 Million) in capital expenditures (€269.00K). Check PHG cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of PHARMING GRP SP. ADRS (2021–2025)
Capital reinvestment ratio of PHARMING GRP SP. ADRS from 2021 to 2025. This chart tracks PHARMING GRP SP. ADRS's Capital Reinvestment Ratio across 3 annual periods. Also explore PHARMING GRP SP. ADRS equity growth rate to track the company's year-over-year net asset growth rate.
PHARMING GRP SP. ADRS Capital Reinvestment Ratio by Year (2021–2025)
PHARMING GRP SP. ADRS capital reinvestment ratio by year from 2021 to 2025. For the full cash flow conversion analysis, see PHG operating cash flow.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | €54.71 Million | €755.00K | ▼ -84.3% |
| 2022 | 0.09x | €22.46 Million | €1.98 Million | ▼ -80.1% |
| 2021 | 0.44x | €37.84 Million | €16.72 Million | — |